
Medical oxygen in short supply in many parts of world: Research
A new article published this week in The Lancet medical journal found that more than half of the world's population lacks access to safe and affordable medical oxygen services, and most people outside of high-income countries go without adequate oxygen services for their medical conditions.
As the Lancet Global Health Commission noted in its report on medical oxygen security, about 374 million people need medical oxygen every year, with roughly 9 million people needing long-term oxygen due to chronic illness.
However, there are gaps in coverage in low- and middle-income countries (LMIC).
'We found that more than 5 billion people—ie, more than 60% of the world's population—do not have access to safe, quality, and affordable medical oxygen services,' the commission wrote. 'In LMICs, only 89 million (30%) of the 299 million people who need oxygen for acute medical or surgical conditions receive adequate oxygen therapy, with the lowest access in sub-Saharan Africa.'
They noted that this coverage gap of 70 percent far exceeds that of treatments for HIV/AIDS and tuberculosis.
Common causes contributing to this gap include not being able to reach facilities, facilities not having the capacity for basic oxygen service, failure to identify the need for oxygen services and low-quality oxygen care.
Earlier this month, an elderly Burmese refugee who depended on oxygen died after being discharged from a U.S.-funded hospital. This reportedly occurred after the hospital was closed following President Trump's order to freeze foreign aid.
The commission estimated it would cost $6 to $8 billion annually to close this coverage gap in LMICs, which they acknowledged was costly while also noting that oxygen services are highly cost-effective.
'The case for investing in medical oxygen is strong: it is as cost-effective as routine childhood immunisation, would enable governments to make progress on eight of the nine [Sustainable Development Goal 3], and could reduce deaths during future pandemics,' they wrote.
To better address this issue, the commission called for more countries to develop national oxygen plans that suit their unique national priorities and conditions. They also called for 'high-quality, robust pulse oximeters' to be made more affordable and accessible for small and rural health facilities, noting this essential measure is conducted in only about a fifth of people presenting at general hospitals in LMICs.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Psychedelics as potential mental health treatment are explored by Trump administration
The Trump administration has expressed interest in exploring psychedelics for their potential in treating PTSD and other debilitating mental health issues, various officials have shared. "The Department shares the goal of ensuring that all Americans — especially our nation's veterans — have access to safe and effective treatments for conditions such as PTSD, addiction and depression," a spokesperson for the U.S. Department of Health and Human Services (HHS), run by Sec. Robert J. Kennedy Jr., said in a statement provided to Fox News Digital. "Secretary Kennedy is committed to applying rigorous, evidence-based science to research efforts aimed at addressing these serious health challenges." Fda Approves First Ai Tool To Predict Breast Cancer Risk In recent years, researchers have been actively investigating the potential of psychedelics, such as MDMA and psilocybin ("magic mushrooms") to treat mental health disorders. MDMA is not approved for clinical use by the U.S. Food and Drug Administration (FDA), but can be studied in clinical settings. Read On The Fox News App Psilocybin is listed as a Schedule I substance under the Controlled Substances Act, which means it has "a high potential for abuse, [is not] currently accepted for medical use in treatment in the United States, and [has] a lack of accepted safety for use under medical supervision." Psilocybin-assisted therapy, however, is legal in Oregon, Colorado and New Mexico. Psychedelic medicines are "showing real promise," according to Dr. Luke Twelves, general practitioner and vice president of medical for Lindus Health in London. Clinical trials have found such treatments safe and effective for patients battling serious mental health issues, according to Twelves. Common Supplements And Medications Could Cause Liver Damage, Studies Show "Take psilocybin, for example — it's demonstrating remarkable results for severe depression that hasn't responded to other medications," he told Fox News Digital. "MDMA is showing similar breakthroughs for PTSD treatment." Clinical trials are also investigating how psychedelics could help with end-of-life anxiety, addiction, eating disorders, chronic pain and OCD, he added. Researchers have faced challenges in terms of regulatory hurdles and proper placebo controls, Twelves said. "Given that these treatments could transform [the] lives of people suffering from conditions where nothing else has worked effectively, it's crucial that we complete this research properly," he said. "The goal is to bring safe, proven psychedelic therapies to the patients who need them most." At President Trump's May 1 cabinet meeting, Department of Veterans Affairs Secretary Doug Collins said that "we're opening up the possibility of psychedelic treatment." Retired Army Sergeant Jonathan Lubecki recently told Fox News' Alexandria Hoff that MDMA stopped his PTSD while he was participating in a clinical trial. "[I] took my first dose of MDMA. I've only taken it three times as part of the clinical trial, haven't taken it since, and haven't found the need to take it since, because I haven't had PTSD," he said. Peter Kasperowicz, Department of Veterans Affairs press secretary, told Fox News Digital the department is safely exploring all avenues that promote the health of veterans. Fallujah Vet Turns Medal Of Heroism Into A Healing Mission For Fellow Warriors With Service Dogs Program "Preliminary findings have produced positive results on psychedelic-assisted therapies for treating mental health conditions," he said. The VA is currently running 11 clinical trials in various phases, with a total of some 800 veterans expected to participate. "The goal of these trials is to determine whether compounds such as MDMA and psilocybin can treat veterans with post-traumatic stress disorder, treatment-resistant depressive disorder, major depressive disorder and potentially other mental health conditions," said Kasperowicz. An MDMA study published in the Jan. 2025 issue of The American Journal of Psychiatry found that the substance is "unlike classical psychedelics." The study noted, "MDMA allows the individual to maintain intact ego functioning and a greater degree of cognitive and perceptual lucidity while still experiencing a prosocial altered state of consciousness that facilitates deeply emotional therapeutic breakthroughs." Click Here To Sign Up For Our Health Newsletter The researchers concluded that MDMA showed "enhanced levels of trust, empathy, self-compassion and a 'window of tolerance'" that traditional psychotherapy lacks. Doug Drysdale, CEO of the Canadian pharmaceutical company Cybin, told Fox News Digital that "the time is now to address the mental health crisis." He said it is "gratifying" that administration officials value the potential benefits of looking into alternative mental health treatments. Cybin is currently in phase 3 of a study of CYB003, a type of psilocybin that has been granted breakthrough therapy designation by the FDA as an additional treatment for major depressive disorder (MDD). "In Cybin's completed Phase 2 MDD study, long-term efficacy results showed that 71% of participants were in remission from depression, and 100% of participants responded to treatment at 12 months after just two 16 mg doses of CYB003," said Drysdale. Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and Fox News' senior medical analyst, previously interviewed two of the country's top researchers on psychedelics — Dr. Rachel Yehuda, founder and director of the Center for Psychedelic Psychotherapy and Trauma Research at Mt. Sinai in New York, and Dr. Charles Marmar, director of the PTSD research program at NYU Langone. "They agree there is therapeutic potential if very carefully studied under very strict medical guidance, but there is a huge downside in terms of unregulated recreational uses," Siegel told Fox News Digital at the time. "Both doctors see likely therapeutic value to psychedelics if carefully managed by medical experts," Siegel added. Ryan Moss, chief science officer at Filament Health, a clinical-stage natural psychedelic drug development company in Canada, emphasized it's important to administer psychedelics in a safe setting when treating mental health conditions. For more Health articles, visit "Psychedelic experiences can sometimes feature anxiety, hallucinations and paranoia," Moss previously told Fox News Digital. "Some patients using traditional psychedelics have reported experiencing adverse cardiovascular events during clinical trials." To mitigate these risks, Moss recommended clinical trial participants receive thorough preparation and monitoring by trained professionals during sessions. Melissa Rudy and Angelica Stabile, both of Fox News Digital, contributed article source: Psychedelics as potential mental health treatment are explored by Trump administration


UPI
4 hours ago
- UPI
'Unite for Vets' rally in Washington, D.C., protest overhaul of VA
1 of 8 | Veterans, military families and demonstrators gather on the National Mall in Washington, D.C.,, to participate in a Unite for Veterans Rally to protest the Trump Administration's cuts to staffing and programs at the Department of Veterans Affairs. Photo by Annabelle Gordon/UPI | License Photo June 6 (UPI) -- Several thousand veterans converged on the National Mall on Friday at a rally among 200 events nationwide against a proposed overhaul that includes staffing reduction and some services shifted. The Veterans Administration counters the new proposed budget is higher than last year, processing of claims have sped up and it's easier to get benefits. Veterans, military families and others participated in the Unite for Veterans, Unite for America Rally on the 81st anniversary of D-Day, which was the Allies' amphibious invasion of German-occupied France. The protests, which were organized by a union, took place at 16 state capitol buildings and more than 100 other places across 43 states. "We are coming together to defend the benefits, jobs and dignity that every generation of veterans has earned through sacrifice," Unite for Veterans said on its website. "Veteran jobs, healthcare, and essential VA services are under attack. We will not stand by." Speakers in Washington included Democrats with military backgrounds: Sen. Tammy Duckworth of Illinois, former Rep. Conor Lamb of Pennsylvania and California Rep. Derek Tran. There were signs against President Donald Trump, VA Secretary Doug Collins and Elon Musk, the multi-billionaire who ran the Department of Government Efficiency. They said those leaders are betraying the country's promises to troops. "Are you tired of being thanked for our service in the public and stabbed in our back in private?" Army veteran Everett Kelly, the national president of the American Federation of Government Employees, asked the crowd. "For years, politicians on both sides of the aisle have campaigned on their support of veterans, but once they get into office, they cut our benefits, our services. They take every opportunity to privatize our health care." The Trump administration plans to cut 83,000 VA staffers and shift more money from the federal health care system to private-sector clinics. The administration's proposed budget for the VA, released on Friday, slashes spending for "medical services" by $12bn - or nearly 20% - an amount offset by a corresponding 50% boost in funding for veterans seeking healthcare in the private sector. The Department of Veterans Affairs employs approximately 482,000 people, including 500,000 workers at 170 hospitals and 1,200 local clinics in the nation's largest health care system. In all, there are 15.8 million veterans, which represents 6.1% of the civilian population 18 years and older. VA officials said the event was misguided. "Imagine how much better off veterans would be if VA's critics cared as much about fixing the department as they do about protecting its broken bureaucracy," VA press secretary Peter Kasperowicz said in a statement to UPI. "The Biden Administration's VA failed to address nearly all of the department's most serious problems, such as rising health care wait times, growing backlogs of veterans waiting for disability compensation and major issues with survivor benefits." Kasperowicz told UPI disability claims backlog is already down 25% since Trump took office on Jan. 20 after it increased 24% during the Biden administration. He said VA has opened 10 new healthcare clinics around the country, and Trump has proposed a 10% budget increase to $441.3 billion in fiscal year 2026. The administration's proposed budget for the VA reduces spending for "medical services" by $12 billion - or nearly 20% - which is offset by a 50% boost in funding for veterans seeking healthcare in the private sector. Kasperowicz said the "VA is accelerating the deployment of its integrated electronic health record system, after the program was nearly dormant for almost two years under the Biden Administration." The event was modeled after the Bonus Army protests of the 1930s, when veterans who served in World War I gathered in the nation's capital to demand extra pay denied after leaving the service. Irma Westmoreland, a registered nurse working at a VA hospital and the secretary-treasurer of National Nurses United, told the crowd in Washington: "It's important for every person to keep their job, from the engineering staff to the housekeeper to the dietary staff. When cuts are made, the nursing and medical staff will have to pick up all their work that needs to be done."
Yahoo
4 hours ago
- Yahoo
Why Oscar Health, Inc. (OSCR) Soared On Thursday
We recently published a list of . In this article, we are going to take a look at where Oscar Health, Inc. (NYSE:OSCR) stands against other best-performing stocks on Thursday. Oscar Health snapped a five-day losing streak on Thursday, jumping 10.6 percent to close at $15.65 apiece as investors resorted to bargain-hunting while waiting for more concrete developments on the Trump administration's Medicare Advantage review. Earlier this year, lawmakers passed a $5-trillion tax-and-spending package that shaves as much as $900 billion in Medicaid, which servers over 70 million low-income households. A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. Now, Senate Republicans to broaden savings by looking for supposed inefficiencies in the Medicare program for senior citizens. In the first quarter of the year, Oscar Health, Inc. (NYSE:OSCR) registered a 55-percent increase in attributable net income of $275 million versus the $177 million registered in the same period last year. Revenues rose by 42 percent to $3.046 billion from $2.142 billion year-on-year. Overall, OSCR ranks 5th on our list of best-performing stocks on Thursday. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data